QCQian Chen

Qian Chen

*This is an algorithmically generated author record based on publicly available information.

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qian Chen has a total of 142 co-authors. Here are the top co-authors by number of shared publications:

  • Shuo Feng

    Department of Neurology, Capital Center for Children’s Health, Capital Medical University

    11 shared publications
  • Ping Zheng

    Department of Epilepsy Center Capital Center for Children's Health, Capital Medical University Beijing China

    9 shared publications
  • Xinna Ji

    Department of Neurology, Capital Center for Children’s Health, Capital Medical University

    9 shared publications
  • Xue Zhang

    State Key Laboratory for Complex Severe and Rare Diseases, Peking Union Medical College Hospital & Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

    8 shared publications
  • Yanyan Gao

    Department of Neurology, Capital Center for Children’s Health, Capital Medical University

    7 shared publications
  • Lina Xie

    Department of Neurology, Capital Center for Children’s Health, Capital Medical University, Beijing, China

    6 shared publications

Latest Publications

  • Open Access

    Balloon cells in type II focal cortical dysplasia: developmental origins, molecular signatures, and epileptogenic mechanisms

    by Yan Gao, Xinna Ji, Shuo Feng, Yanyan Gao, Lingxue Li, Bing Wang, Xue Zhang, Qian Chen

    Type II focal cortical dysplasia (FCD II) is a major cause of drug-resistant epilepsy in children, with balloon cells representing a defining histopathological feature of FCD IIb. Although diagnostically important, the biological identity and epileptogenic contribution of balloon cells remain incompletely understood. Current evidence links balloon cells to disrupted cortical development, often driven by somatic mosaic mutations in the PI3K-AKT-mTOR pathway, resulting in impaired differentiation, cellular enlargement, and hybrid neuroglial phenotypes. This review examines current evidence on the developmental origins and lineage states, molecular signatures, electrophysiological features, and network effects of balloon cells in FCD II. Persistent mTOR hyperactivation appears to interact with cytoskeletal abnormalities, oxidative stress, and local inflammatory signaling, thereby creating a microenvironment that favors epileptogenic remodeling. Despite being largely electrically silent, BCs are embedded within lesion microenvironments characterized by disrupted inhibitory circuitry, altered neurotransmitter homeostasis, and complement-associated synaptic remodeling. BCs may participate indirectly in these processes, although their cell-specific causal contribution remains unresolved. Recent single-cell and spatial transcriptomic studies further distinguish balloon cells from dysmorphic neurons and implicate them in local immune activation. Understanding balloon cell biology may reveal cell-specific therapeutic targets and support precision treatment strategies beyond surgical resection.

  • Open Access

    Configuration-Level Genetic Interpretation in Neurodevelopmental Disorders: A Single-Center Cohort of 2162 Children in China

    by Lingxue Li, Dawei Cheng, Bing Wang, Fan Wu, Xinna Ji, Qian Chen

    Background/Objectives: Compound heterozygosity, multilocus molecular diagnoses, mosaicism, uniparental disomy (UPD), and mitochondrial DNA (mtDNA) heteroplasmy are established configuration-dependent diagnostic categories whose interpretation requires consideration of allelic phase, dosage, parental origin, and tissue distribution. This study evaluated their diagnostic contribution and clinical characteristics in pediatric neurodevelopmental disorders (NDDs). Methods: This single-center retrospective cohort study conducted a descriptive cross-phenotypic evaluation of 2162 children in China who underwent clinical genetic testing between 2015 and 2024. The primary analysis focused on confirmed diagnostic configurations, whereas study-defined possibly diagnostic configurations were included only in expanded-set sensitivity and supplementary descriptive analyses. Binary clinical outcomes were adjusted for sex, calendar year of testing, and primary testing strategy. Ascertainment depended on the genetic tests performed for each child rather than systematic screening for all five categories. Results: Confirmed diagnostic configurations were identified in 166/1009 (16.5%) children with definitive molecular diagnoses, corresponding to 166/2162 (7.7%) of the full cohort. These comprised 103 compound heterozygous configurations, 24 multilocus molecular diagnoses, 19 mosaic findings, 4 UPD-related configurations, and 16 mtDNA heteroplasmy configurations. An additional 34 children had possibly diagnostic configurations, yielding an expanded configuration set of 200/2162 (9.3%), which was not interpreted as a definitive diagnostic yield. In the confirmed-only analysis, age at onset was lower than in the comparison group (median 1.80 vs. 2.80 years, Bonferroni-adjusted p = 0.008), and epilepsy was less frequent [94/166 (56.6%) vs. 1338/1962 (68.2%), Bonferroni-adjusted p = 0.035]. Conclusions: Confirmed diagnostic configurations involving these five categories accounted for 16.5% of definitive molecular diagnoses and were characterized by a lower frequency of epilepsy at the cohort level. Configuration-level assessment of allelic phase, dosage, multilocus contribution, parental origin, mosaic fraction, and tissue context may improve diagnostic completeness and recurrence-risk counseling.

  • Open Access

    A de novo IKZF4 Variant Underlies Hypogammaglobulinemia and Increased Infection Susceptibility through Downregulating the NF-κB Pathway

    by Shiqi Fan, Rongrong Wang, Kaichen Tang, Lina Xie, Qian Chen, Miao Sun, Xue Zhang

    Purpose Inborn errors of immunity (IEI) are a group of complex diseases characterized by reduced immunity and increased susceptibility to external pathogens, autoinflammation, autoimmune conditions, and/or malignancy. The IKAROS zinc-finger (IKZF) family is a group of C2H2 zinc-finger transcription factors that includes IKAROS (IKZF1), HELIOS (IKZF2), AIOLOS (IKZF3), EOS (IKZF4), and PEGASUS (IKZF5). Variants in IKZF have been reported to cause human IEI except IKZF4. This research aimed to identify the pathogenicity and underlying mechanisms of IKZF4 as a novel candidate gene for IEI. Methods Here, we used whole-exome sequencing to identify candidate variants of IEI. Western blotting, quantitative polymerase chain reaction, immune staining, co-immunoprecipitation, flow cytometry, Luminex assays, and single-cell RNA sequencing were used to explore the phenotypes and functional effects in cell and mouse models. Results An 11-month-old patient presented with repeated fever and convulsions accompanied by persistently reduced immunoglobulin levels and abnormal immune indices, which supported the diagnosis of IEI. A de novo c.1472delG variant (GRCh37/hg19, NM_022465.3) in IKZF4 was selected as the candidate variant for IEI. The c.1472delG variant caused reduced EOS expression and truncated protein (predicted molecular weight ~ 57 kDa), defective pericentromeric heterochromatin targeting, and impaired protein interactions of EOS. A mouse model harboring the corresponding variant in Ikzf4 (Ikzf4+/c.1475delG) showed a proinflammatory switch in regulatory T cells, accompanied by reduced levels of immunoglobulins and a decreased ratio of marginal zone B cells after lipopolysaccharide stimulation, which were potentially caused by the down-regulated transcriptional regulation of EOS on the nuclear factor kappa-B pathway. Conclusion This research identified IKZF4 as a novel candidate gene for IEI, advancing our knowledge of the IKZF family and the complexity of human IEI.

  • Cerebral Small Vessel Disease in a Neonate

    by Ye Han, Ping Zheng, Xinna Ji, Qian Chen

  • Open Access

    Genetic testing and analysis of 1024 children with global developmental delay or intellectual disability: a single-center cohort study

    by Bing Wang, Xinna Ji, Fan Wu, Mengyao Shen, Ping Zheng, Shuo Feng, Huanhuan Wu, Shupin Li, Aijie Liu, Lina Xie, et al.

    Global developmental delay (GDD) and intellectual disability (ID) are common neurodevelopmental disorders with a strong genetic basis. However, comprehensive large-cohort analyses integrating genotype–phenotype correlations and functional mechanisms remain limited. This study aimed to systematically characterize the clinical and genetic spectrum of GDD/ID in a large single-center cohort and to explore the functional attributes of disease-causing genes. We retrospectively analyzed 1024 children diagnosed with GDD or ID who underwent genetic testing, including trio whole-exome sequencing (trio-WES), proband-only WES, and clinical exome sequencing. Clinical phenotypes were categorized, and functional enrichment analyses were conducted for genes associated with diagnostic and probable diagnostic results. A genetic diagnosis was achieved in 48.1% of patients, with trio-WES demonstrating a significantly higher diagnostic yield than proband-only approaches. Pathogenic variants mainly comprised single-nucleotide variants and copy number variants. Identified genes were predominantly involved in protein homeostasis, synaptic and ion channel function, epigenetic regulation, and key developmental signaling pathways. Distinct genotype–phenotype associations were observed among clinical subgroups, including enrichment of synaptic-related genes in epilepsy-associated GDD/ID and epigenetic regulatory genes in patients with facial dysmorphism. Conclusion: This study provides a comprehensive characterization of the genetic landscape of GDD/ID in a large single-center cohort and identifies distinct genotype–phenotype correlations and convergent molecular pathways underlying these disorders. What is Known: • Global developmental delay (GDD) and intellectual disability (ID) are highly heterogeneous neurodevelopmental disorders with a strong genetic basis. What is New: • We report a large single-center cohort of 1024 children with GDD/ID, providing a comprehensive overview of the genetic landscape and diagnostic yield of different sequencing strategies. • Our study systematically integrates genotype–phenotype correlations with functional pathway analyses, highlighting key molecular mechanisms underlying GDD/ID and supporting refined molecular stratification.


  • Open Access

    Diagnostic Genetic Findings From Exome Sequencing in a Cohort of 1,109 Children With Epilepsy

    by Fan Wu, Xinna Ji, Peidi Cheng, Suzhou Zhao, Shuo Feng, Wanting Liu, Jinxiao Chen, Xue Zhang, Hongxing Wang, Qian Chen

    Genetic testing has emerged as a transformative tool for the diagnosis and treatment of epilepsy. The aim of this study was to characterize the genetic basis of pediatric epilepsy. We analyzed a cohort of 1,109 children with epilepsy who underwent whole-exome sequencing. Genetic findings were interpreted based on medical records and genetic testing results. Genetic diagnostic results were found in 405 of 1,109 patients, with a diagnostic yield of 36.5%. The SCN1A (40/1,109, 3.6%) was the most frequently affected gene, followed by the PRRT2 (26/1,109, 2.3%) and SCN2A (10/1,109, 0.9%). In total, 138 genes were identified with 337 total detections. Gene ontology analysis revealed enrichment in ion channel–related genes (30.0%, 101/337), catalytic activity–related genes (19.6%, 66/337), and pathway-related genes (14.5%, 49/337). Multivariate logistic regression showed that younger age at onset (OR = 0.87, 95% CI 0.81–0.94, p < 0.001), developmental delay or intellectual disability (OR = 2.25, 95% CI 1.62–3.12, p < 0.001), and facial dysmorphisms (OR = 2.30, 95% CI 1.06–5.00, p = 0.036) were associated with a higher likelihood of achieving a genetic diagnosis. Negative results were obtained in 51.4% (570/1,109) of patients. This single-center study provides a comprehensive overview of the genetic landscape of pediatric epilepsy, enhancing our understanding of the genetic basis and offering insights for clinical diagnosis and genetic counseling. These findings underscore the clinical utility of genetic testing in pediatric epilepsy.


  • Open Access

    Whole exome sequencing identifies KCNH7 variants associated with epilepsy in children

    by Fan Wu, Xinna Ji, Mengxiao Shen, Peidi Cheng, Shuo Feng, Yanyan Gao, Wanting Liu, Jinxiao Chen, Shupin Li, Xue Zhang, et al.


  • Accelerating the diagnosis of Chinese cblC type MMA patients by multiplex PCR sequencing method

    by Ping Zheng, Chaoji Yu, Lina Xie, Xinna Ji, Shuo Feng, Yanyan Gao, Xing Wei, Wenli Wu, Qian Chen

    Background CblC type methylmalonic aciduria (cblC disease) is the most common inborn error of vitamin B12 metabolism and due to mutations in the MMACHC gene. The earlier the diagnosis, the better the prognosis. Therefore, convenient and inexpensive detection method is needed. Methods This study selected mutational hot-spot regions in the MMACHC gene which harbors more than 90% of mutant alleles responsible for cblC disease in China. Subsequently, a hot-spot regions multi-PCR Sanger sequencing method (HsRMSS) was designed. The accuracy and efficiency of HsRMSS was validated using samples from 20 cblC families with known MMACHC gene mutations and 50 healthy volunteers. In addition, patients’ clinical phenotypes and molecular genetic features were analyzed. Results A total of 16 different mutations were identified in 20 cblC families. Among them, the most common mutations were c.609 G>A (26/80, 32.5%), c.567dupT (10/80, 12.5%), c.80A>G (8/80, 10.0%), c.658_660delAAG (8/80, 10.0%) and c.394C>T (6/80, 7.5%), which accounted for over 70% of disease alleles. The HsRMSS results were the same as the results using the whole exon sequencing, with a coincidence rate of 100%. Conclusion The HsRMSS targeting the mutational hot-spots of MMACHC gene could be a promising tool to accurately and rapidly diagnose cblC disease in China. Impact This study reported the development and validation of a hot-spot regions multi-PCR Sanger sequencing method for targeting hotspots which harbor most of the common MMACHC gene mutations reported in Chinese patients with cblC disease. The approach could have a potential clinical application as a rapid diagnosis and screening tool for suspected children with cblC type MMA and population carrier, owing to its high throughput, low cost, and high sensitivity and specificity.